“We are committed to developing safe, high-impact vaccines that can be delivered to the disadvantaged people of developing countries in an affordable and sustainable manner.”
The vicious gap prevailing between the health standards of the developing and developed world is increasing with every passing year and the only way to curb this is to develop effective and affordable health care facilities.
Public health systems that can ensure fairness in global health scenario will be a reality only through easy and affordable access to life-saving immunization programs. Well equipped with transformational vaccine research technologies, we will deliver new age preventive healthcare to the developing world in the near future.
Our expertise in vaccine research is channelized towards helping people in the developing world to fight the deadliest of diseases with vaccines that are within their reach. A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is an international organization strengthened by the presence of global leadership and scientific team, which is working incessantly to develop safe, effective, affordable and sustainable vaccines for developing countries.
We endeavour to create a novel immunization platform by employing ultra modern techniques and focusing on :
- Reduced footprint
Hilleman Laboratories will invest the majority of its resources in the research and clinical assessment of vaccines against strains of diseases prevalent in the developing world, which bears 90% of the global burden of disease. Additionally, it will forge partnerships with governments, policy makers, multilateral and international organizations, public-private sector, research and technical institutes, NGOs, philanthropic organizations and other like-minded institutions. We aim to collaborate, exchange ideas and build a meaningful dialogue and advocacy towards affordable vaccine discovery that will strengthen the public health systems and immunization programs in developing countries.